Pan-cancer analysis of TCGA and GTEx datasets revealed significantly elevated MRPL3 expression across different cancer types, including BLCA, BRCA, CESC, CHOL, COAD, DLBC, and PAAD, compared to that in normal tissues (Figure 1A). This evidence concerns the gene MRPL3 and cancer.